Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
18 Nov 2008 Pharming And Aslan Group Sign License Agreement For Lactoferrin
18 Nov 2008 IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Europe from the Committee for Medicinal Products for Human Use (CHMP)
18 Nov 2008 FDA reschedules Advisory Committee meeting for liraglutide - no change of review timeline anticipated
17 Nov 2008 Start of the Phase II clinical trial with Elafin
17 Nov 2008 BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon
17 Nov 2008 Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3 Clinical Trials of Hematide(TM)
14 Nov 2008 Generex Launches Oral Insulin for Diabetes Management in India; Retail Availability Coincides With World Diabetes Day
14 Nov 2008 ThromboGenics Announces Promising Six Month Follow-Up Results from its Phase IIb Trial of Microplasmin (MIVI III) for Treatment of Visual Disorders
14 Nov 2008 Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society’s Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
13 Nov 2008 Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail(R) Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti-Obesity Peptide
13 Nov 2008 BioLineRx and Yissum Sign a Licensing Agreement for the Development of a Novel Compound for the Treatment of Inflammatory Bowel Disease
13 Nov 2008 Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
13 Nov 2008 Affymax Completes Enrollment in EMERALD 1, the Third of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients
13 Nov 2008 BioSeek Licenses Two Novel Anti-Inflammatory Peptides
13 Nov 2008 Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
12 Nov 2008 Antyra Enters into Licensing Agreement for Anticancer Agents from Novo Nordisk A/S
12 Nov 2008 Biovitrum Extends ReFacto(R) Supply Agreement with Wyeth until December 31, 2015
12 Nov 2008 ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
10 Nov 2008 Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure
07 Nov 2008 Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease
06 Nov 2008 Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
06 Nov 2008 Proteon Therapeutics Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia
05 Nov 2008 ConjuChem Provides Development Update
05 Nov 2008 SciClone and Sigma-Tau Report Phase 3 Hepatitis C Trial Results
04 Nov 2008 ZymoGenetics Presents Positive Interim Phase 1b Results in Hepatitis C
04 Nov 2008 Derma Sciences Enrolls First Patient in DSC127 Phase II Study
04 Nov 2008 FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
04 Nov 2008 Sanvar(R) (Debio 8609) for esophageal variceal bleeding - Debiopharm submits response to the FDA
03 Nov 2008 BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
03 Nov 2008 Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients
03 Nov 2008 Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
31 Oct 2008 Savient Submits Biologics License Application (BLA) for pegloticase
29 Oct 2008 FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
29 Oct 2008 Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme(R)
29 Oct 2008 BioMimetic Therapeutics Reports Promising Clinical Results Using Augment Injectable Bone Graft to Treat Distal Radius Fractures
29 Oct 2008 Alvine Pharmaceuticals Reports Positive Results With ALV003 in Phase 1 Trial of Therapy in Development for Celiac Disease
28 Oct 2008 Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
28 Oct 2008 Cytheris Initiates Asian Phase I/IIa Clinical Trial of Interleukin-7 (IL-7) as an Immunotherapy in HCV Patients
27 Oct 2008 PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
24 Oct 2008 Merck Serono Submits Application for GONAL-f(R) in Japan for Ovulation Induction in Infertile Women
24 Oct 2008 Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
23 Oct 2008 Proteolix Presents Solid Tumor Clinical Trial Results for Carfilzomib at EORTC-NCI-AACR International Conference
23 Oct 2008 Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
22 Oct 2008 ZymoGenetics Presents Interim IL-21 Phase 2 Results in Renal Cell Cancer
22 Oct 2008 Targanta Therapeutics Releases Results from Phase 2 Simplifi Study Evaluating Single or Infrequent Doses of Oritavancin
21 Oct 2008 Emisphere Announces Initiation of Second Phase III Study for Oral Osteoarthritis Treatment
20 Oct 2008 Acceleron Initiates Phase 1 Clinical Trial for ACE-031 to Treat Diseases Involving Muscle Loss
20 Oct 2008 Discovery Labs Submits Complete Response to May 2008 FDA Approvable Letter for Surfaxin(r) for RDS
17 Oct 2008 New data from head-to-head phase 3 trial demonstrate that liraglutide is more effective than exenatide in treatment of type 2 diabetes
16 Oct 2008 Immutep Announces IND Allowance in Pancreatic Cancer
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 1429

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics